EUVIMEDEUVIMED entdecken
Vergleichsstudie

Chronic kidney disease progression with proton pump inhibitors versus H2 receptor antagonists in NSAID users

Susin Park iD, Pusoon Chun iD

Journal of Nephrology · 30.10.2026 · 39 (8) · 1687-1696

DOI: 10.1093/joneph/aajag176 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Journal of Nephrology, online erschienen am 03.09.2026. Verfasst von Susin Park und 1 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmacy, Kyungsung University, Busan, Republic of Korea. Hauptthemen laut MEDLINE: Proton Pump Inhibitors, Histamine H2 Antagonists, Renal Insufficiency, Chronic, Anti-Inflammatory Agents, Non-Steroidal. Die Arbeit nennt 30 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Clinical evidence comparing the renal impact of proton pump inhibitors (PPIs) and Histamine-2 receptor antagonists (H2RAs) in patients with chronic kidney disease (CKD) receiving traditional non-steroidal anti-inflammatory drugs (tNSAIDs) is lacking. We evaluated CKD progression risk associated with PPIs versus H2RAs within a tNSAID-treated cohort to inform clinical prescribing.

Methods

This retrospective cohort study used South Korean nationwide claims data (2018–2023). Stabilized inverse probability of treatment weighting (SIPTW) balanced the cohorts. Restricted cubic spline Cox regression addressed non-linear associations between CKD progression and cumulative exposure to tNSAIDs and acid suppressants (PPIs or H2RAs). Sensitivity analyses addressing unspecified CKD stages confirmed the robustness of the primary findings.

Results

Among 141 093 tNSAID initiators with CKD prescribed PPIs (n = 5315) or H2RAs (n = 7112), PPIs were associated with higher CKD progression risk than H2RAs (adjusted hazard ratio [aHR] 1.38, 95% CI 1.10–1.74). Baseline comorbidities—hypertension (aHR 2.03, 95% CI 1.37–2.99]), diabetes (1.69 [1.29–2.21]), and a history of kidney disease (1.43 [1.13–1.81])—and prior diuretic use (2.00 [1.56–2.58]) were associated with increased risk of CKD progression. In contrast, dapagliflozin or empagliflozin use was protective (0.49 [0.27–0.89]). The risk of CKD progression for PPIs relative to H2RAs was most pronounced in females, those with CKD stage 3, patients aged ≥71 years, and those with 1–15 days of treatment (all P < .05).

Conclusion

Our findings suggest that H2RAs may be associated with a lower risk of CKD progression than PPIs in tNSAID users with CKD, potentially offering a safer alternative when PPI therapy is not indispensable.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Proton Pump InhibitorsHistamine H2 AntagonistsRenal Insufficiency, ChronicAnti-Inflammatory Agents, Non-SteroidalHumansFemaleDisease ProgressionRetrospective StudiesMaleAgedMiddle AgedRepublic of KoreaRisk Factors

Stichwörter der Autor:innen

H2 receptor antagonistschronic kidney diseasenon-steroidal anti-inflammatory drugsproton pump inhibitors

Substanzen

Proton Pump InhibitorsHistamine H2 AntagonistsAnti-Inflammatory Agents, Non-Steroidal

Autor:innen und Institutionen

  • College of Pharmacy, Kyungsung University, Busan, Republic of Korea.
  • College of Pharmacy and Inje Institute of Pharmaceutical Sciences and Research, Inje University, Gimhae, Gyeongnam Republic of Korea.

ORCID-Profile: Susin Park, Pusoon Chun

Zitieren

APA

Park, S., & Chun, P. (2026). Chronic kidney disease progression with proton pump inhibitors versus H2 receptor antagonists in NSAID users. Journal of Nephrology, 39(8), 1687-1696. https://doi.org/10.1093/joneph/aajag176

Vancouver

Park S, Chun P. Chronic kidney disease progression with proton pump inhibitors versus H2 receptor antagonists in NSAID users. Journal of Nephrology. 2026;39(8):1687-1696. doi:10.1093/joneph/aajag176

BibTeX
@article{Park2026,
  author = {Park, Susin and Chun, Pusoon},
  title = {Chronic kidney disease progression with proton pump inhibitors versus H2 receptor antagonists in NSAID users},
  journal = {Journal of Nephrology},
  year = {2026},
  volume = {39},
  number = {8},
  pages = {1687--1696},
  doi = {10.1093/joneph/aajag176}
}
Kostenlos starten →